ATE190725T1 - Test für lipopolysaccharide antigene - Google Patents

Test für lipopolysaccharide antigene

Info

Publication number
ATE190725T1
ATE190725T1 AT96305901T AT96305901T ATE190725T1 AT E190725 T1 ATE190725 T1 AT E190725T1 AT 96305901 T AT96305901 T AT 96305901T AT 96305901 T AT96305901 T AT 96305901T AT E190725 T1 ATE190725 T1 AT E190725T1
Authority
AT
Austria
Prior art keywords
test
lipopolysaccharide antigens
lipopolysaccharide
antigens
chapso
Prior art date
Application number
AT96305901T
Other languages
English (en)
Inventor
Jeanette Elizabeth Brid Menton
Paul Raymond Sheard
Original Assignee
Unipath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unipath Ltd filed Critical Unipath Ltd
Application granted granted Critical
Publication of ATE190725T1 publication Critical patent/ATE190725T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56927Chlamydia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96305901T 1995-09-14 1996-08-12 Test für lipopolysaccharide antigene ATE190725T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95306506 1995-09-14

Publications (1)

Publication Number Publication Date
ATE190725T1 true ATE190725T1 (de) 2000-04-15

Family

ID=8221332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96305901T ATE190725T1 (de) 1995-09-14 1996-08-12 Test für lipopolysaccharide antigene

Country Status (5)

Country Link
US (1) US6159703A (de)
JP (1) JP3534952B2 (de)
AT (1) ATE190725T1 (de)
DE (1) DE69607095T2 (de)
ES (1) ES2145388T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018634A1 (en) * 2002-07-29 2004-01-29 Kiamars Hajizadeh Sample-collection and preparation device and method
US7585641B2 (en) * 2003-01-21 2009-09-08 Agdia, Inc. Immunoassay and method of use
US7815854B2 (en) 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US7796266B2 (en) 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
JP6096586B2 (ja) * 2013-05-10 2017-03-15 デンカ生研株式会社 蛍光色素で標識された可視域着色不溶性担体粒子の調製とそれを用いたイムノアッセイ法
DE102014220090B3 (de) * 2014-10-02 2015-10-08 Abf Diagnostics Gmbh Probennahmevorrichtung mit Probenaufarbeitungsfunktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4914041A (en) * 1988-02-12 1990-04-03 Beckman Instruments, Inc. Reagent and method for detecting rheumatoid factor
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
GB8820375D0 (en) * 1988-08-26 1988-09-28 Boots Celltech Diagnostics Assay
ATE108557T1 (de) * 1989-04-14 1994-07-15 Unilever Nv Extraktionsverfahren.
JP3524120B2 (ja) * 1992-05-08 2004-05-10 生化学工業株式会社 前処理剤、前処理方法、前処理された試料による測定法、測定用キット及び試料の判定方法
US5302405A (en) * 1992-08-31 1994-04-12 Campbell Soup Company Method for removing cholesterol and fat from egg yolk by chelation and reduced-cholesterol egg product
EP0608546A3 (en) * 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.

Also Published As

Publication number Publication date
DE69607095D1 (de) 2000-04-20
JPH09127110A (ja) 1997-05-16
JP3534952B2 (ja) 2004-06-07
DE69607095T2 (de) 2000-11-02
ES2145388T3 (es) 2000-07-01
US6159703A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
DE69607095D1 (de) Test für lipopolysaccharide Antigene
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
TR199701252T1 (xx) Bir saponin ve bir sterol i�eren a��lar.
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
EP1064303A4 (de) Monoklonale antikörper spezifisch für die extrazelluläre domäne des prostata-spezifischen membranantigens
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
AUPN627595A0 (en) Diagnostics and treatments of periodontal disease
MX9602688A (es) Metodo para cuantificar la lbp en fluidos de cuerpo.
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
ES2196150T3 (es) Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
IL123736A0 (en) Tryptase polyclonal antibody and purification method for use in human immunoassay
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
NO954386D0 (no) Elektrokjemiluminescensfremgangsmåte
ES2123774T3 (es) Metodo y composicion para la reduccion de la fosfatasa alcalina endogena.
ES2056378T3 (es) Procedimiento de extraccion.
ES2082132T3 (es) Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos.
DE69610948D1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
DE69606739D1 (de) Elastisches Lager für schwingende Masse
MX9706229A (es) Composicion detergente que comprende una enzima de amilasa y un eter de polisacarido no ionico.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2125011T3 (es) Procedimiento inmunologico de la antitrombina iii activada por un glicosaminoglicano, anticuerpos monoclonales correspondientes y su procedimiento de obtencion.
ATE269400T1 (de) Katabolisch nicht reprimierte substrat- beschränkte hefe-stämme
DE69627324D1 (de) Verfahren zum biologischen abbau von polyorganosiloxanen durch einen mikroskopischen pilz und aufspürungsmethode
CA2081879A1 (en) Monoclonal antibodies to polyacrylate polymers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties